Regulation of BAX/BAK-Dependent Cell Death
Regulation of BAX/BAK-Dependent Cell Death
批准号:
7228869
负责人:
EMILY H CHENG
金额:
$14.46万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-07 至 2008-04-30
关键词:
Adaptor Signaling ProteinAffectApoptosisApoptoticAspartateAutoimmune DiseasesBAK1 geneBAX geneBax proteinBindingBiochemicalBiochemical GeneticsBiological ModelsBiological ProcessCaenorhabditis elegansCaspaseCell DeathCell NucleusCell membraneCellsCessation of lifeCleaved cellComplexCysteine ProteaseDeath DomainDevelopmentDistalDoctor of PhilosophyEnzyme PrecursorsEnzymesFamily memberFluorescence Resonance Energy TransferFunctional disorderGene TargetingGeneticHomeostasisHomologous GeneInfertilityMaintenanceMalignant NeoplasmsMammalsMediatingMitochondriaMolecular ConformationMutationNematodaNeurodegenerative DisordersNuclear EnvelopeOrganOrganellesParticipantPathologic ProcessesPathway interactionsPhaseProcessProtein FamilyProteinsProteolysisRegulationReticulumRoleSignal TransductionSiteSpecificityTestingTissuesapoptotic protease-activating factor 1caspase-3caspase-6caspase-9cell suicideconformercytochrome cgenetic analysisgenetic regulatory proteinin vivoloss of functionmembermitochondrial dysfunctionmouse modelnovelpreventprograms
中文摘要
描述(由申请人提供):BCL-2蛋白家族,包括抗凋亡和促凋亡成员,构成细胞死亡途径中的关键检查点。这些成员对维持主要器官的稳态至关重要,影响它们的突变可能导致癌症。“仅bh3”分子激活“多结构域”促凋亡成员BAX和BAK,触发线粒体依赖的细胞死亡途径,释放细胞色素c激活caspase并启动caspase非依赖性线粒体功能障碍。相反,抗凋亡的BCL-2/BCL-XL在稳定的线粒体复合体中隔离易位的“仅bh3”分子,从而阻止BAX/BAK的激活。功能丧失研究表明,促凋亡的BAX和BAK的缺失会严重阻碍由质膜、细胞核和内质网等多个部位启动的多种死亡信号引发的细胞凋亡。因此,“多结构域”促凋亡成员BAX或BAK的激活似乎是线粒体介导的细胞死亡程序的重要门户。是什么使BAK在线粒体中保持非活性构象,以及它是如何被激活并在细胞死亡中表现出来的,目前尚不清楚。我推断可能存在一种额外的死亡调节蛋白,并确定了一种仅与BAK的非活性构象相互作用的BAK相互作用蛋白,并在BAK被“仅bh3”分子激活时从BAK中移位。对这种新参与者(名为X)的进一步表征及其确切影响将进一步了解“仅bh3”蛋白如何激活BAK和线粒体死亡途径。在此背景下,我提出以下具体目标:(1)分析“多结构域”促凋亡BAX和BAK介导线粒体功能障碍和细胞死亡的机制;(2)确定bak相互作用蛋白(X)在调控细胞凋亡中的作用。
英文摘要
DESCRIPTION (provided by applicant): The BCL-2 family of proteins, consisting of both anti-apoptotic and pro-apoptotic members, constitutes a crucial checkpoint in the cell death pathway. These members are essential for maintenance of major organ homeostasis, and mutations affecting them can result in cancer. The "BH3-only" molecules activate "multi-domain" pro-apoptotic members BAX and BAK to trigger a mitochondrion-dependent cell death pathway, which both releases cytochrome c to activate caspases and initiates caspase-independent mitochondrial dysfunction. Conversely, anti-apoptotic BCL-2/BCL-XL sequesters translocated "BH3-only" molecules in stable mitochondrial complexes, thus preventing the activation of BAX/BAK. Loss of function studies revealed that the absence of pro-apoptotic BAX and BAK creates a profound block in apoptosis triggered by diverse death signals initiated at multiple sites including plasma membrane, nucleus, and endoplastic reticulum. Thus, activation of a "multidomain" pro-apoptotic member, BAX or BAK, appears to be an essential gateway to the mitochondria-mediated cell death program. What maintains BAK in an inactive conformation at mitochondria and precisely how it is activated to manifest in cell death are still unclear. I reasoned that an additional death regulatory protein might exist and have identified a BAK-interacting protein that only interacts with the inactive conformer of BAK and is displaced form BAK upon its activation by "BH3-only" molecules. Further characterization of this novel participant (entitled X) and its precise effects will further understanding of how "BH3-only" proteins activate BAK and the mitochondrial death pathway. In this context, I propose the following specific aims: (1) Dissect the mechanisms by which "multidomain" pro-apoptotic BAX and BAK mediate mitochondrial dysfunction and cell death; (2) Determine the role of BAK-interacting protein (X) in regulating apoptosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
-
批准号:10525194
-
项目类别:
-
资助金额:$53.4万
-
财政年份:2022
-
负责人:EMILY H CHENG
-
依托单位:
Project III: Engineering immunogenic cell death in melanoma and renal cell carcinoma.
-
批准号:10705788
-
项目类别:
-
资助金额:$49.56万
-
财政年份:2022
-
负责人:EMILY H CHENG
-
依托单位:
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
-
批准号:10375572
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2021
-
负责人:EMILY H CHENG
-
依托单位:
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
-
批准号:10211264
-
项目类别:
-
资助金额:$51.36万
-
财政年份:2021
-
负责人:EMILY H CHENG
-
依托单位:
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
-
批准号:10621724
-
项目类别:
-
资助金额:$50.33万
-
财政年份:2021
-
负责人:EMILY H CHENG
-
依托单位:
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
-
批准号:10392931
-
项目类别:
-
资助金额:$52.18万
-
财政年份:2018
-
负责人:EMILY H CHENG
-
依托单位:
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
-
批准号:9916771
-
项目类别:
-
资助金额:$55.08万
-
财政年份:2018
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:8697656
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:7359675
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:9487176
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:7268258
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:9064083
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:7758306
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:10005603
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:7587268
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Apoptotic Network Integrated at the Mitochondrion
-
批准号:8018174
-
项目类别:
-
资助金额:$32.78万
-
财政年份:2007
-
负责人:EMILY H CHENG
-
依托单位:
Regulation of BAX/BAK-Dependent Cell Death
-
批准号:6951525
-
项目类别:
-
资助金额:$14.46万
-
财政年份:2003
-
负责人:EMILY H CHENG
-
依托单位:
Regulation of BAX/BAK-Dependent Cell Death
-
批准号:6746841
-
项目类别:
-
资助金额:$14.02万
-
财政年份:2003
-
负责人:EMILY H CHENG
-
依托单位:
Regulation of BAX/BAK-Dependent Cell Death
-
批准号:7064784
-
项目类别:
-
资助金额:$14.46万
-
财政年份:2003
-
负责人:EMILY H CHENG
-
依托单位:
Regulation of BAX/BAK-Dependent Cell Death
-
批准号:6560786
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2003
-
负责人:EMILY H CHENG
-
依托单位:
海外基金